AMOREPACIFIC Group Overview
AMOREPACIFIC Holdings is the pure holding company of Korea's oldest and largest pure-play beauty group. Through AMOREPACIFIC Corporation and its sister beauty subsidiaries (INNISFREE, ETUDE, espoir, AMOS PROFESSIONAL) and the OSULLOC tea business, it owns more than 30 brands across luxury skincare (Sulwhasoo, AMOREPACIFIC), masstige and digital-native skincare (LANEIGE, COSRX, INNISFREE), derma (AESTURA, ILLIYOON), makeup (HERA, ETUDE, espoir) and hair care (RYO, Mise-en-Scène, LABO-H). FY2025 consolidated revenue was KRW 4.62tn, up 8.5%, and operating profit was KRW 368.0bn, up 47.6%, the highest since 2019. The group is in the late stage of a "global rebalancing." It is cutting dependence on mainland China and Korean duty-free, and redeploying toward the Americas, EMEA, Japan and cross-border e-commerce (Amazon, Sephora, TikTok Shop). The equity trades at a deep holding-company discount (about 0.5x book). That discount reflects double-layer minority interests, family control and a subsidiary-driven earnings stream.
Company's own description (paraphrased from the Q1 2026 quarterly report)
The holding company classifies its consolidated operations into two segments, Cosmetics and Other. In Q1 2026 these accounted for about 95% and 5% of consolidated revenue respectively; in Q2 2026 the split was 96% / 4% [Src: Holdings Q1 2026 quarterly report, KIND, 15 May 2026; Butler.works segment data]. The company groups its sales routes into three channel buckets. In Q1 2026 their revenue shares were:
-
pure domestic Korea: 43%
-
duty-free and cross-border: 12%
-
overseas subsidiaries and exports: 45%
[Src: Holdings and AP Corp Q1 2026 quarterly reports]. The operating subsidiary AMOREPACIFIC Corp. describes itself as researching, developing, manufacturing and selling cosmetics and beauty products worldwide. Its scope also includes medical beauty, beauty devices, inner beauty, hair/body/dental care, tea products, detergents and chemical compounds, packaging, facility management and equipment design [Src: StockHub company profile summarising DART descriptions].
The group's vision since September 2025 is "Create New Beauty", which aims at leadership in global beauty and wellness. It is executed through five priorities: Everyone Global, Holistic, Ageless, AMORE Spark and AI First [Src: AP Holdings FY2025 earnings release, 6 Feb 2026].
Business and revenue model (independent characterisation)
| Dimension | Characterisation |
|---|---|
| Revenue model | Almost entirely product revenue: branded cosmetics, personal care, hair care and tea. There are no material subscription or licensing streams. Some service-like income exists, such as Jeju tea-museum F&B at OSULLOC (Matcha Station, Matcha Noodle Bar), but it is immaterial at group level [Src: Q2 2026 release] |
| Holding-company income | At standalone level, Holdings earns dividends, brand royalties/fees and rental income from subsidiaries. Standalone revenue is not separately broken out in the sources reviewed (n/d) |
| Value-chain position | Vertically integrated: in-house R&I (Yongin), owned manufacturing (Osan Amore Beauty Park and others), brand ownership, and a mix of owned retail, wholesale/distributor and DTC/e-commerce. Packaging and facilities were historically handled in-house through group affiliates |
| Customer types | Mainly consumers. Trade customers include multi-brand shops (Olive Young domestically; Sephora, Ulta-type specialty, Boots internationally), department stores, duty-free operators, e-commerce platforms (Amazon, TikTok Shop, Qoo10, Coupang), distributors (e.g., Silicon2 for Europe) and salons (AMOS PROFESSIONAL) |
| End-markets | Prestige and luxury skincare, masstige skincare, derma-cosmetics, colour cosmetics, hair care and styling, body and oral care, premium tea |
| Earnings concentration | AMOREPACIFIC Corp. delivered KRW 4,252.8bn of revenue and KRW 335.8bn of OP in FY2025. That is 92% of group revenue and 91% of group OP (computed) [Src: FY2025 earnings release] |
The structural fact that matters most for equity holders is the ownership chain. Holdings and related parties own about 50% of AMOREPACIFIC Corp. (50.14% at 31 Mar 2026) [Src: AP Corp Q1 2026 quarterly report]. Non-controlling interests therefore absorb most consolidated profit. In FY2025, profit attributable to owners of Holdings was KRW 124.0bn out of KRW 292.2bn of total net income, or 42% (computed) [Src: Valueline consolidated IS].
Strategy
Stated corporate strategy (themes, paraphrased)
Vision "Create New Beauty": (announced for the 80th anniversary, Sept 2025): aims at global leadership in beauty and wellness [Src: Q3 2025 and FY2025 releases].
Five strategic priorities: 1. Everyone Global: concentrate on core global markets.
-
Holistic: integrated beauty solutions spanning skin, hair, body, inner beauty and devices.
-
Ageless: biotech-based anti-ageing innovation.
-
AMORE Spark: agile organisational transformation.
-
AI First: AI-driven work transformation. [Src: FY2025 and Q2 2026 releases.]
AP Corp 2025 AGM agenda ("Global Brand Company"): four pillars [Src: Dealsite; Ajunews, 25 Mar 2025]:
-
A competitive brand portfolio: scale LANEIGE and COSRX; incubate AESTURA and HERA; reinvigorate Sulwhasoo and RYO.
-
Global rebalancing: focus markets are the US, Japan, Europe, India and the Middle East, with China restructuring to be finished within 2025.
-
Global channel responsiveness, especially e-commerce platforms.
-
Future growth through AI and data.
Earlier management agenda "Grow Together": brand value, global rebalancing and customer-centric management [Src: Q1 2025 release].
Initiatives register (last 24 months)
| Date | Initiative | Detail | Source |
|---|---|---|---|
| Late 2024 – 2026 | Corporate value-up plan | Phased treasury cancellation (3m shares Feb 2025; 3m shares Q1 2026); medium-term dividend policy promised | Dealsite, Feb–Mar 2025 |
| 2023–2025 | AP Corp dividend policy | Payout ratio around 35%, with dividends within 50% of annual FCF | Shinhan Investment, Jul 2024 |
| Mar 2025 | Holdings rename | Clarifies the holding-company role | KIND; Dealsite |
| Jun 2025 | North America leadership | Giovanni Valentini named CEO, North America | Beauty Packaging |
| 2,025 | Western brand launches | AESTURA and HANYUL launched in the US; IOPE and ILLIYOON added in 2026 | FY2025 and Q2 2026 releases |
| 2,025 | China restructuring | Shift in transaction structure; Sulwhasoo counter closures; China profitable from Q1 2025 | Q2 2025 release; Meritz |
| Q4 2025 | Workforce restructuring | Voluntary retirement: KRW 53.6bn one-off cost, about KRW 20bn annual savings | Yuanta, Feb 2026 |
| Q4 2025 | COSRX distribution reset | Distribution network restructured; growth resumed in Q4 2025 led by The Peptide | FY2025 release |
| Q1 2026 | Medical-aesthetic adjacency | KRW 80bn LP commitment to a VIG Partners fund that acquired Viol (beauty and medical devices); described as an indirect, collaboration-led investment | Dealsite, Jun 2026 |
| Mar 2026 | AI commerce | Amoremall app launched inside ChatGPT | itwiki summary |
| May 2026 | E-commerce partnerships | "2026 All About Amore" event with key e-commerce partners | itwiki summary |
| Ongoing | Sustainability | RE100 (100% renewable across sites targeted by 2025); SBTi 1.5°C-aligned net zero; Scope 1+2 -90% vs 2020 by 2050 | Beauty Packaging; AP news, Dec 2025 |
Medium-term targets and guidance
Overseas mix target: 70% of revenue from overseas by 2035 [Src: secondary summary (Wikidocs); not confirmed in a primary filing, so treat with caution].
Near-term guidance: following FY2025 results, management guided to mid-single-digit revenue growth and a low-teens operating margin for the near term (reported by Yuanta in the context of Q1 2026) [Src: Yuanta, 9 Feb 2026]. Formal multi-year numeric targets for Holdings: n/d.
Margin trajectory: Hanwha expects AP Corp's consolidated OPM to exceed 10% in the medium term if current restructuring trends hold [Src: Kukinews, 9 Feb 2026].
Products & Services
Retail price points are not disclosed in filings. The pricing model throughout is per-unit retail/wholesale.
Cosmetics segment: AMOREPACIFIC Corp. brands
| Brand | Positioning / category | Named flagship products and recent launches (sourced) | Target customer | Heritage year | Notes |
|---|---|---|---|---|---|
| Sulwhasoo | Luxury ginseng-based skincare; Korea's leading luxury skincare brand per company | First Care Activating Serum (hero); Concentrated Ginseng Rejuvenating Collection, reformulated Mar 2025; Jaumsaeng line; "Jihambo" luxury gift-wrapping service [Src: Q2 2026 release; Beauty Packaging; FY2025 release] | Affluent 35+ consumers; gifting; duty-free and tourist shoppers | 1997 (n/v) | China department-store footprint being restructured [Src: Meritz, Feb 2026] |
| AMOREPACIFIC (brand) | Ultra-premium skincare | n/d in sources reviewed | Luxury department-store consumers | n/v | Grew 58% in North America in Q2 2026 per SK Securities, though it is unclear whether SK meant the brand or the "AP brands" aggregate |
| HERA | Korea's leading luxury makeup brand per company; No.1 cushion foundation brand in Korea | Sensual Nude Gloss; Mesh Powder Cushion; entered Japanese department stores in 2025 [Src: Q2 2026 and FY2025 releases] | Urban women 20s–40s | 1995 (n/v) | — |
| LANEIGE | Hydration-focused masstige/premium skincare and lip; lead global brand | Lip and skincare lines; Balance Mode line (Japan, 2026); JuicePop Box Tint with K-pop group Katseye as global partner [Src: Q2 2026 release; Personal Care Insights] | Gen Z and millennials, global | 1994 (n/v) | Strong at Amazon, Sephora and Boots (UK) |
| COSRX | Hypoallergenic, sensitive-skin, ingredient-led skincare; digital-native | Advanced Snail line (n/v); The RX line (Retinol 0.1 Cream, Vitamin C 23 Serum, co-developed with AP); "The Peptide" line (2025); Ultra-Light Invisible Sunscreen, No.1 in Amazon Beauty in Germany and No.1 sunscreen on Amazon UK in Q2 2026; hair-care line [Src: Retail Dive; FY2025 and Q2 2026 releases] | Global online shoppers, sensitive-skin users | 2013 [Src: Cosmetics & Toiletries] | 93.2% owned; more than 90% of revenue overseas, over 45% from North America [Src: Dealsite, May 2025] |
| AESTURA | Korea's leading derma brand per company; barrier-repair dermocosmetics | ATOBARRIER365 Cream: triple-digit US growth via Amazon and Sephora (Q2 2026) [Src: Q2 2026 release] | Sensitive and atopic skin; dermatology-minded consumers | n/v | No.1 derma brand share at Olive Young in 2023 [Src: AP news, Jan 2024] |
| ILLIYOON | Mass derma body care | No.1 body-care brand at Olive Young (Q2 2026) [Src: Q2 2026 release] | Families, sensitive skin | n/v | Launched in the US recently [Src: Q2 2026 release] |
| IOPE | Science-led anti-ageing skincare | Recently introduced in the Americas [Src: Q2 2026 release] | 30s–40s | 1984 (n/v) | — |
| HANYUL | Natural Korean-botanical skincare | US launch in 2025 [Src: FY2025 release] | Natural-skincare consumers | n/v | — |
| Primera | Sprout-based gentle skincare | MBS channel growth (Q2 2026) [Src: Q2 2026 release] | Clean-beauty consumers | n/v | — |
| Mamonde | Flower-based skincare; rebranded for Gen Z/Alpha | Entered Europe via cross-border channels (2025) [Src: FY2025 release] | Gen Z, Gen Alpha | n/v | — |
| Tata Harper | US farm-to-face clean luxury skincare | — | US clean-luxury consumers | n/v | Acquired 2022 [Src: AP Corp Q1 2026 report] |
| RYO (려) | Herbal anti-hair-loss and scalp care | Root:Gen (루트젠) anti-ageing line, launched 2025 [Src: AP news, Apr 2025] | Hair-loss and scalp-concern consumers | n/v | Growth in North America and Greater China |
| Mise-en-Scène | Hair styling and treatment | Perfect Serum, No.1 hair-styling oil on Amazon Black Friday 2025; Salon 10 Peptide Repair line (2026); TikTok Shop expansion [Src: FY2025, Q1 and Q2 2026 releases] | Mass consumers | n/v | — |
| LABO-H | Scalp-strengthening "clinic" hair care | Hairline Ampoule; renewed scalp-strengthening clinic line; scalp sun care [Src: Q2 2026 release] | Thinning-hair consumers | n/v | — |
| Makeon / beauty devices | Beauty-tech devices | — | Home-device users | n/v | Device strategy reinforced by the KRW 80bn indirect investment in Viol (medical-aesthetic devices) [Src: Dealsite, Jun 2026] |
| Other daily-beauty / oral / body (e.g., Happy Bath, Median; n/v) | Mass personal care | — | Mass households | n/v | Daily-beauty portfolio rebuilt around premium lines [Src: AP news, Jan 2024] |
Cosmetics segment: holding-company beauty subsidiaries
| Brand / entity | Positioning | Flagship / recent (sourced) | Target customer | Heritage year | FY2025 Rev / OP (KRW Bn) |
|---|---|---|---|---|---|
| INNISFREE | Jeju-nature masstige skincare | Green Tea line; sun care; US rebrand (Mar 2025) [Src: Beauty Packaging; Q2 2026 release] | Teens to 30s, global | 2000 (n/v) | 209.8 / 13.3 |
| ETUDE | Playful colour cosmetics | Curl Fix Mascara; lip and face makeup in MBS channels [Src: Cosmetics Design Europe; Q3 2025 release] | Teens to 20s | 1985 (n/v) | 115.1 / 10.0 |
| espoir | Professional-artist makeup; premium foundation | No.1 premium-foundation share claim (2023) [Src: Hankyung, Jan 2024] | Makeup enthusiasts | 2001 (n/v) | 77.2 / -0.5 |
| AMOS PROFESSIONAL | Salon hair care (B2B2C) | "Salon Connection" stylist-network programme [Src: Hankyung, Jan 2024] | Hair salons and professionals | n/v | 79.1 / 7.0 |
Other segment
| Entity | Description | Recent (sourced) | FY2025 Rev / OP (KRW Bn) |
|---|---|---|---|
| OSULLOC | Premium Korean tea brand (green tea, matcha, gift sets, tea houses) | Passed KRW 100bn revenue for the first time; Jeju Tea Museum renewal; Matcha Station; Matcha Noodle Bar; Haeundae tea house [Src: FY2025 and Q2 2026 releases; Hankyung] | 110.9 / 11.5 |
| OSULLOC Farm | Tea cultivation, Jeju | — | — |
| Pacific Tech | Listed in the "Other Subsidiaries" grouping; function n/d in sources reviewed | — | — |
Financial Narrative
Income statement (chartable)
[Src: Dealsite, 9 Feb 2022 (FY2021); Dealsite, 1 Feb 2023 (FY2022); AP news, 30 Jan 2024 (FY2023); DART-based summaries (FY2024); FY2025 earnings release and DART preliminary results (FY2025); Butler.works and etfshopping 5-year series (NI). Margins computed.]
Revenue CAGR (computed): FY2021–FY2025 was -3.5% a year. FY2023–FY2025 was +7.2% a year, which marks the turning point.
FY2025 detailed P&L and TTM (chartable)
[Src: Valueline/DataHero consolidated IS (FY2025 column and TTM to Jun 2026). Margins computed. Basic vs diluted EPS split n/d; the convertible preferred implies some dilution at conversion in 2029.]
Supplementary P&L items (non-chartable)
[Src: Valueline DPS series (TTM DPS of 330 to Sep 2025 and 400 from Dec 2025); Simply Wall St (higher FY2025 dividend). DPS for FY2021–FY2023: n/d.]
Balance sheet (chartable; year-end)
[Src: Valueline/DataHero consolidated BS. Gross financial debt is computed as short-term borrowings plus short- and long-term financial liabilities as classified by the data provider. These may include lease liabilities; the debt/lease split is n/d. No bonds outstanding in any period shown. Net debt computed versus cash and equivalents only. FY2021 balance sheet: n/d in sources reviewed.]
Cash flow (chartable; partial history)
[Src: IB Tomato, Dec 2025, citing the Holdings cash-flow statement; FY2025 from Valueline.]
[Src: Valueline/DataHero CF statement. FY2021–FY2024 OCF, capex and FCF: n/d in sources reviewed. Treasury shares cancelled in 2025–26 came from existing holdings, not new purchases. TTM investing outflow includes the KRW 80bn commitment to the VIG Partners vehicle that acquired Viol (Q1 2026).]
Commentary on trends, inflections and drivers
FY2021 (post-COVID rebound). Revenue rose 8.0% to KRW 5.33tn and OP rose 136.4% to KRW 356.2bn. The drivers were online growth of about 40% and strong duty-free (daigou) sales, while the cost base had been cut through offline store closures [Src: Dealsite, Feb 2022]. In hindsight this was a peak built on China-linked channels.
FY2022–FY2023 (China shock). Revenue fell 15.6% and then a further 10.5%, and OP fell to KRW 152.0bn in FY2023. Three forces drove the decline: China's zero-COVID lockdowns, the collapse of daigou-driven Korean duty-free sales, and deliberate destocking and channel cleanup in China [Src: Dealsite, Feb 2023; AP news, Jan 2024]. AP Corp's overseas business swung to a KRW 43.2bn loss in FY2023 even as the Americas grew 58% [Src: AP news, Jan 2024].
FY2024 (rebalancing plus COSRX). Revenue grew 5.9% and OP rose 64% to KRW 249.3bn. COSRX was consolidated from 1 May 2024, and goodwill more than doubled from KRW 594bn to KRW 1,281bn. Total intangibles rose by about KRW 1.4tn. Reported net income of KRW 652.9bn far exceeded OP. This reflects non-operating gains associated with the COSRX step-acquisition accounting (remeasurement of the previously held 38.4% stake), which AP Corp's FY2024 controlling NI of KRW 593bn also shows [Src: Hanwha, Apr 2026]. The exact gain is n/d in the sources reviewed. FY2024 NI should therefore be treated as non-recurring.
FY2025 (profit inflection). Revenue grew 8.5% and OP rose 47.6% to KRW 368.0bn, a six-year high. Overseas OP at AP Corp roughly doubled to KRW 209.9bn. The overseas margin reached about 11% (computed), above the domestic margin of about 6.4% for the first time in the period shown. The Q4 2025 voluntary retirement programme cost KRW 53.6bn at AP Corp and is expected to save about KRW 20bn of annual labour cost [Src: Yuanta, Feb 2026]. Net income fell 55% because the FY2024 one-off did not recur.
H1 2026 (operating leverage). Revenue was KRW 2,477bn (+9.6%) and OP was KRW 261bn (+24.7%). The H1 operating margin was 10.5% and the Q2 gross margin rose to 75.3% from 74.2% [Src: Quartr Q2 2026 summary]. Q2 marketing spend rose 37% and SG&A rose 12.1%, so the margin expansion came from gross-margin mix (COSRX, AESTURA and the Western business) rather than cost cutting.
Balance sheet. The group is essentially unlevered. It held net cash of about KRW 290bn at June 2026, had no bonds outstanding, and interest coverage was 18.6x. The main balance-sheet "risk" is intangible concentration: COSRX-related goodwill and intangibles of about KRW 1.4tn sit against a brand whose revenue declined in parts of 2025. Inventory days of about 160 are high in absolute terms but typical for a multi-brand prestige beauty company.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Holdings consolidated revenue (KRW Bn) | 5,326.1 | 4,495.0 | 4,021.3 | 4,259.9 | 4,623.2 |
Holdings consolidated operating profit (KRW Bn) | 356.2 | 271.9 | 152.0 | 249.3 | 368.0 |
AMOREPACIFIC Corp. revenue (KRW Bn) | 4,863.1 | 4,134.9 | 3,674.0 | 3,885.1 | 4,252.8 |
AMOREPACIFIC Corp. operating profit (KRW Bn) | 343.4 | 214.2 | 108.2 | 220.5 | 335.8 |
AMOREPACIFIC Corp. share of group revenue (%) | 91.3 | 92.0 | 91.4 | 91.2 | 92.0 |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
AP Corp domestic revenue (KRW Bn) | 3,075.7 | 2,581.3 | 2,210.8 | 2,166.9 | 2,275.2 |
AP Corp overseas revenue (KRW Bn) | 1,802.3 | 1,493.5 | 1,391.8 | 1,660.1 | 1,909.1 |
AP Corp domestic operating profit (KRW Bn) | 300.0 | 218.2 | 146.4 | 147.9 | 144.9 |
AP Corp overseas operating profit (KRW Bn) | 51.8 | 8.1 | -43.2 | 104.2 | 209.9 |
AP Corp overseas OP margin (%) | 2.9 | 0.5 | -3.1 | 6.3 | 11.0 |
Group Entities
| Subsidiary | FY2023 OP | FY2024 Rev (derived) | FY2024 OP (derived) | FY2025 Rev | FY2025 OP | FY2025 YoY Rev / OP |
|---|---|---|---|---|---|---|
INNISFREE | 10.3 | 225.6 | 1.6 | 209.8 | 13.3 | -7% / +716% |
ETUDE | 14.8 | 107.6 | 9.1 | 115.1 | 10.0 | +7% / +10% |
espoir | 2.2 | 70.2 | n/d (profit) | 77.2 | -0.5 | +10% / turned to loss |
AMOS PROFESSIONAL | 12.6 | 79.2 | 11.1 | 79.1 | 7.0 | -0.1% / -37% |
OSULLOC | 5.5 | 94.0 | 9.2 | 110.9 | 11.5 | +18% / +25% |
Results by Segment
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 1,164.8 | 1,095.0 | 1,108.2 | 1,255.2 | 1,222.7 | 1,254.3 |
Operating profit (KRW Bn) | 128.9 | 80.1 | 104.3 | 54.8 | 137.8 | 122.8 |
Net income (KRW Bn) | — | 50.8 | — | 18.1 | 56.2 | 104.5 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 5,326.1 | 4,495.0 | 4,021.3 | 4,259.9 | 4,623.2 |
Revenue growth YoY (%) | 8.0 | -15.6 | -10.5 | 5.9 | 8.5 |
Operating profit (KRW Bn) | 356.2 | 271.9 | 152.0 | 249.3 | 368.0 |
Operating margin (%) | 6.7 | 6.0 | 3.8 | 5.9 | 8.0 |
Net income incl. NCI (KRW Bn) | 292.0 | 149.2 | 234.7 | 652.9 | 292.2 |
Net margin (%) | 5.5 | 3.3 | 5.8 | 15.3 | 6.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (FY2025–TTM Jun 2026)
| Metric | FY2025 | TTM Jun 2026 |
|---|---|---|
Revenue (KRW Bn) | 4,623.2 | 4,840.5 |
Cost of sales (KRW Bn) | 1,220.8 | 1,258.1 |
Gross profit (KRW Bn) | 3,402.4 | 3,582.4 |
Gross margin (%) | 73.6 | 74.0 |
SG&A (KRW Bn) | 3,034.4 | 3,162.8 |
of which advertising (KRW Bn) | 640.3 | 715.1 |
of which commissions/fees (KRW Bn) | 858.7 | 894.7 |
of which R&D (KRW Bn) | 105.6 | 105.8 |
Operating profit (KRW Bn) | 368.0 | 419.6 |
EBITDA (KRW Bn) | 676.6 | 750.7 |
EBITDA margin (%) | 14.6 | 15.5 |
Pre-tax income (KRW Bn) | 395.8 | 476.5 |
Income tax (KRW Bn) | 103.7 | 138.2 |
Net income incl. NCI (KRW Bn) | 292.2 | 338.3 |
Net income attributable to owners (KRW Bn) | 124.0 | 138.3 |
EPS, controlling basis (KRW) | 1,324 | 1,513 |
Income Statement and Per-Share Data
| Item | FY2024 | FY2025 |
|---|---|---|
Gross profit (KRW Bn) | — | 3,402.4 |
EBITDA (KRW Bn) | — | 676.6 |
EPS basic, controlling (KRW) | — | 1,324 |
DPS, common (KRW) | 330 | 400 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|---|
Total assets (KRW Bn) | 7,651.0 | 7,631.4 | 8,540.5 | 8,769.4 | 8,912.8 |
Current assets (KRW Bn) | 2,566.4 | 2,750.2 | 2,583.3 | 2,875.0 | 3,037.9 |
Cash and equivalents (KRW Bn) | 650.1 | 629.0 | 564.4 | 596.6 | 614.0 |
Short-term financial assets (KRW Bn) | 239.8 | 221.6 | 88.7 | 108.6 | 90.9 |
Inventories (KRW Bn) | 460.0 | 462.8 | 569.7 | 539.1 | 566.3 |
Goodwill (KRW Bn) | 597.0 | 594.3 | 1,281.3 | 1,280.7 | 1,282.2 |
Total intangibles incl. goodwill (KRW Bn) | 856.4 | 841.2 | 2,276.6 | 2,225.0 | 2,211.5 |
Current liabilities (KRW Bn) | 851.9 | 856.2 | 1,138.1 | 1,144.2 | 1,150.4 |
Short-term borrowings (KRW Bn) | 240.9 | 277.1 | 326.2 | 256.3 | 230.7 |
Other ST financial liabilities (KRW Bn) | 70.6 | 53.5 | 59.5 | 47.0 | 45.2 |
LT financial liabilities (KRW Bn) | 55.7 | 43.5 | 65.9 | 42.3 | 47.6 |
Total liabilities (KRW Bn) | 1,117.5 | 1,106.3 | 1,548.8 | 1,534.0 | 1,548.3 |
Equity attributable to owners (KRW Bn) | 3,356.4 | 3,323.3 | 3,335.6 | 3,482.2 | 3,529.0 |
Non-controlling interests (KRW Bn) | 3,177.1 | 3,201.8 | 3,656.1 | 3,753.3 | 3,835.4 |
Total equity (KRW Bn) | 6,533.5 | 6,525.1 | 6,991.7 | 7,235.4 | 7,364.4 |
Working capital (KRW Bn) | 1,714.5 | 1,894.0 | 1,445.2 | 1,730.8 | 1,887.5 |
Gross financial debt (KRW Bn) | 367.2 | 374.1 | 451.6 | 345.6 | 323.5 |
Net debt (KRW Bn; negative = net cash) | -282.9 | -254.9 | -112.8 | -251.0 | -290.5 |
Dividends & Capital Returns
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Dividends paid, consolidated (KRW Bn) | 105.3 | 53.8 | 67.1 | 98.0 |
Cash Flow
| Metric | FY2025 | TTM Jun 2026 |
|---|---|---|
Operating cash flow (KRW Bn) | 629.7 | 572.2 |
Capex: PP&E (KRW Bn) | 76.8 | 81.5 |
Capex: intangibles (KRW Bn) | 30.1 | 27.8 |
Free cash flow, provider definition (KRW Bn) | 440.2 | 335.3 |
Investing cash flow (KRW Bn) | -357.3 | -490.6 |
Financing cash flow (KRW Bn) | -247.0 | -261.7 |
Share buybacks (KRW Bn) | 0.0 | 0.0 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE, total NI / year-end total equity (%) | 2.3 | 3.6 | 9.3 | 4.0 |
ROA, total NI / year-end assets (%) | 1.9 | 3.1 | 7.6 | 3.3 |
Current ratio (x) | 3.01 | 3.21 | 2.27 | 2.51 |
Total liabilities / total equity (%) | 17.1 | 17.0 | 22.2 | 21.2 |
Gross financial debt / total equity (%) | 5.6 | 5.7 | 6.5 | 4.8 |
Ratio (FY2025 unless stated) | Value | Basis | — | — |
ROE, controlling basis | 3.56% (TTM Jun 2026: 3.92%) | Valueline | — | — |
ROIC | 5.23% (TTM Jun 2026: 5.75%) | Valueline | — | — |
Interest coverage (EBIT / interest) | 16.3x (TTM Jun 2026: 18.6x) | Valueline | — | — |
Net debt / EBITDA | Net cash (about -0.37x) | Computed | — | — |
Asset turnover | 0.53x | Computed: revenue / average assets | — | — |
Days inventory | about 161 days | Computed: inventory 539.1 / COGS 1,220.8 | — | — |
Days sales outstanding | about 30 days | Computed: trade receivables 386.2 / revenue | — | — |
Days payables | about 26 days | Computed: trade payables 86.9 / COGS | — | — |
Cash conversion cycle | about 166 days | Computed | — | — |
Revenue by Region and Region Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
AP Corp Americas revenue (KRW Bn) | 287 | 525 | 630 |
AP Corp EMEA revenue (KRW Bn) | 52 | 170 | 241 |
Americas YoY growth (%) | 58 | 83 | 20 |
EMEA YoY growth (%) | 82 | 229 | 42 |
Revenue by Region
| Metric | FY2024 | FY2025 |
|---|---|---|
AP Corp Greater China revenue (KRW Bn) | 510 | 453 |
AP Corp Other Asia incl. Japan (KRW Bn) | 532 | 585 |
Share Price and Market Valuation
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | YTD2026 |
|---|---|---|---|---|---|
Share price, period end (KRW) | 34,900 | 29,250 | 20,800 | 26,850 | 24,500 |
Market capitalisation (KRW Bn) | 2,877.8 | 2,411.9 | 1,715.1 | 2,133.5 | 1,907.6 |
Price / book (x) | 0.82 | 0.73 | 0.51 | 0.61 | 0.54 |
Valuation Multiples
| Multiple | AMOREPACIFIC Holdings | AMOREPACIFIC Corp. | Note |
|---|---|---|---|
P/E | 13.8x (TTM, 15 Oct 2026) | 26.2x (2026E, Hanwha Apr 2026) | Holdings on controlling EPS |
P/B | 0.54x | 1.8x (2026E) | Holding discount |
EV/EBITDA | about 7.3x TTM (computed, look-through) | 12.5x (2026E) | Holdings EV = market cap 1,907.6 + NCI 3,835.4 + gross financial debt 323.5 − cash 614.0 = KRW 5,452.5bn, against TTM EBITDA of KRW 750.7bn |
EV/Sales | about 1.13x TTM (computed) | — | Same EV basis |
Dividend yield | 1.63% (KRW 400 / KRW 24,500, computed) | 1.3% (2026E) | Holdings common |
Analyst Conclusions
Management guidance
-
Near-term ambition (per Yuanta's Feb 2026 reading): mid-single-digit revenue growth with a low-teens operating margin.
-
Strategic ambition: an overseas-led mix, with 70% overseas by 2035 cited in secondary sources (n/v).
H1 2026 delivered revenue growth of +9.6% and an OPM of 10.5%, which is running ahead of the revenue guide [Src: Quartr].
Consensus expectations
AP Corp: 2026E revenue +7.7% to KRW 4,582bn and OP +35% to KRW 454bn. 2027E OP KRW 496bn (+9%) [Src: Hanwha, Apr 2026]. Yuanta has 2026E OP of KRW 430bn and 2027E of KRW 470bn [Src: Yuanta, Feb 2026].
Holdings: formal consensus for Holdings is thin (one broker). Its earnings track AP Corp, with roughly 50% attribution.
Bull case
-
Margin runway. The overseas OPM of about 11% (FY2025) and double-digit levels in Q1–Q2 2026 point toward group OPM above 10% as Western mix rises. The FY2025 baseline was 8.0%, and every point of margin adds about KRW 46bn of OP (computed).
-
COSRX and AESTURA as compounding Western engines. COSRX grew 53% in Q2 2026 and AESTURA grew at triple-digit rates in the US, while China drag is now small and profitable.
-
Valuation asymmetry. At 0.54x book and about 7x look-through EV/EBITDA, continued cancellations and dividend growth could narrow the holding discount. Insiders have been buying shares in the market (Sept 2026).
Bear case
-
Quality of Q2 2026 beat. About KRW 19bn of customs refunds flattered results [Src: Yuanta]. Q1 2026 overseas OP fell 18% while marketing spend rose 37% in Q2. Margin gains may stall as reinvestment rises.
-
Indie disruption and platform risk. APR earns roughly the same OP on one-third of the revenue. Amazon and TikTok dependence brings algorithmic and pricing risk, and COSRX has already shown volatility.
-
Structural discount persists. Family control, chairman/CEO duality and the double-layer minority structure leave owners only about 42% of consolidated earnings. Controlling ROE below 4% does not justify a re-rating without a structural change.
Catalysts and monitorables (next 12 months)
-
Q3 2026 results (29 Oct 2026): Western growth rates, overseas OPM, COSRX trajectory, and how much of Q2's one-offs recur.
-
FY2026 results (around Feb 2027): DPS increase and any formal multi-year shareholder-return policy or further cancellations.
-
China: stabilisation of North Asia revenue after the counter closures.
-
M&A: any move from the Viol LP stake toward control; bolt-ons in devices, derma or the US.
-
Impairment testing of COSRX goodwill at year-end 2026.
-
The 2029 convertible-preferred conversion (dilution) and any governance reforms (board independence, a separate chair).
Analyst verdict
AMOREPACIFIC Holdings has completed the hardest part of its post-China reinvention. Between FY2023 and FY2025, the operating subsidiary moved from overseas losses to a roughly 11% overseas margin. Group operating profit rose about 2.4x to KRW 368bn, and H1 2026 extended the trend with a 10.5% margin. This progress came from real channel and brand building: LANEIGE in Boots and Amazon, AESTURA in Sephora, COSRX on TikTok Shop, and HERA in Japanese department stores. It did not come from a cyclical China rebound. The balance sheet is pristine and holds net cash, and the ESG profile is best-in-class among Korean consumer companies.
The listed holding company remains a weak vehicle for that operating improvement. Holdings captures only about 42% of consolidated profit. Controlling-basis ROE is below 4%. Governance is concentrated, with the chairman serving as co-CEO of both listed entities and the family controlling about two-thirds of common. Indie K-beauty peers show a margin template (about 24%) that Amorepacific's heavier, multi-brand, owned-manufacturing model is unlikely to match. The roughly KRW 1.28tn of COSRX-related goodwill is a latent risk if the brand's recovery falters.
Net-net, Holdings offers leveraged optionality on AP Corp's margin story at a deep discount: 0.54x book, about 7x look-through EV/EBITDA, a rising dividend and continuing cancellations. The investment case improves materially if any of three things happens:
Codified capital return: management turns value-up into a codified, multi-year return policy.
Margin breakthrough: AP Corp sustains group OPM above 10% through 2027 without one-offs.
Governance reform: board independence and chair/CEO separation improve.
Without those, the discount is likely to persist even as fundamentals improve. AP Corp is then the cleaner expression of the K-beauty globalisation thesis, and Holdings is a value and yield vehicle whose re-rating depends on governance rather than growth.
Stance (analytical, not investment advice): Fundamentals improving. Valuation undemanding. Structural discount the key swing factor.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / appointment | Background | Born |
|---|---|---|---|---|
Suh Kyung-bae | Chairman; Co-CEO and Inside Director (largest shareholder) | Inside director re-elected 15 Mar 2024; CEO of the holding company; ran the business from 1997 | Son of founder Suh Sung-whan; led the 2002 rebrand and 2006 holding structure | 1963 [Src: Yahoo Finance] |
Lee Sang-mok | Co-CEO and Inside Director | CEO since 17 Mar 2023; re-elected 26 Mar 2026 | Joined 2003; finance specialist; led treasury, legal, IP and HQ construction from 2016; Group Planning head from 2021 | 1970 [Src: Dealsite, Dec 2022] |
Ahn Jae-sung | Inside Director (new) | Elected 26 Mar 2026 | Previously SVP, Business Law Division / Chief Compliance Officer | — |
Kim Ae-mi | Outside Director (new) | Elected 26 Mar 2026 | — | — |
Kim Eon-su | Outside Director | Re-elected 26 Mar 2026 | — | — |
Choi Jong-hak | Outside Director | Elected 24 Mar 2022 (current status n/v) | — | — |
Lee Eun-jeong; Chae Kyu-ha | Outside Directors | Elected 17 Mar 2023 (current status n/v) | — | — |
Lee Byung-gon | Head, Future Growth Division (filing officer) | Current | — | — |
Board of Directors — Kim Seung-hwan
| Name | Title | Tenure | Background |
|---|---|---|---|
Kim Seung-hwan | CEO and Inside Director | CEO since 17 Mar 2023; re-elected 26 Mar 2026 | Joined 2006; strategy and HR; CEO of the holding company 2021–22. Born 1969 per Dealsite; Yahoo lists 1970 (discrepancy noted) |
Suh Kyung-bae | Co-CEO and Inside Director | Re-elected Mar 2024 | See above |
Lim Un-seop | Inside Director (new) | Elected 26 Mar 2026 | — |
Lee Ji-yeon | Inside Director | Elected 15 Mar 2024 | — |
Lee Jae-yeon; Ahn Hee-jun | Outside Directors | Lee re-elected and Ahn newly elected 26 Mar 2026 | — |
Park Tae-jin; Lee Eui-kyung | Outside Directors | Elected 25 Mar 2025 | — |
Cho Sung-jin | Outside Director | Elected 15 Mar 2024 | — |
Giovanni Valentini | CEO, North America | Appointed June 2025 | n/d [Src: Beauty Packaging] |
Governance Overview
| Item | Assessment |
|---|---|
Chair/CEO separation | None. Suh Kyung-bae is both chairman and co-CEO at Holdings and AP Corp |
Board independence | Outside directors meet Korean statutory minimums for large listed companies (exact current ratio n/v) |
Committees | Audit Committee, Outside Director Nomination Committee and an ESG/Sustainability committee are typical. The AP ESG board is cited in 2022 disclosures [Src: AP news, Dec 2022]. Full committee roster n/v |
ISS Governance QualityScore | 3 (1 = lowest risk, 10 = highest). Pillars: Audit 1, Board 4, Shareholder Rights 2, Compensation 1 (as of 1 Jun 2024) [Src: Yahoo Finance/ISS] |
Insider ownership | Largest shareholder and related parties hold 66.29% of Holdings common (60.72% of total issued shares) after executives bought 13,651 shares on 9–15 Sep 2026 [Src: Toyo Economy, 22 Sep 2026] |
Family economic interest | Suh Kyung-bae also holds 1,577,121 preferred shares (11.65% of the preferred class). More than half of consolidated dividend outflow is estimated to reach the owner family [Src: IB Tomato, Dec 2025] |
Competitive Landscape
Competitors by Segment
| Segment | Competitors (named) |
|---|---|
Global prestige and luxury skincare | L'Oréal (Luxe), The Estée Lauder Companies, Shiseido, LVMH (Perfumes & Cosmetics), LG H&H (The History of Whoo) |
Masstige / digital-native K-skincare | APR (medicube), The Founders (Anua), d'Alba, Goodai Global (portfolio of indie K-brands), Beiersdorf (Nivea), Unilever |
Derma-cosmetics | L'Oréal Dermatological Beauty (La Roche-Posay, CeraVe), Beiersdorf (Eucerin, Aquaphor), Pierre Fabre (Avène) |
Makeup (Korea / Asia) | LG H&H (VDL, CNP), Clio, Kosé, L'Oréal (Maybelline), Estée Lauder (M·A·C) |
Hair care | LG H&H, L'Oréal, Kao, Unilever |
Korea domestic beauty | LG H&H, APR, Aekyung Industrial, Clio |
Peer Comparison FY2025
| Company | FY / basis | Revenue | YoY growth (%) | OP margin (%) | R&D intensity (%) |
|---|---|---|---|---|---|
AMOREPACIFIC Holdings | FY2025, KRW | KRW 4,623.2bn | 8.5 | 8.0 | 2.3 |
LG H&H (total company) | FY2025, KRW | KRW 6,360bn | -6.7 | 2.7 | — |
APR | FY2025, KRW | KRW 1,527.3bn | 111 | 23.9 | — |
The Estée Lauder Companies | FY to 30 Jun 2026, USD | US$15,049m | 5 | 5.2 reported / 11.2 adjusted | — |
Recent Developments
No layoffs beyond the Q4 2025 voluntary retirement programme, and no guidance withdrawals, litigation or regulatory sanctions, were identified in this window.



